TreatGx ^Plus predicts your response to medications by analyzing medication-to-medication, medication-to-disease, and medication-to-genetic interactions. This personalized analysis leads to ideal medication and dosage options for you, so that safer and more effective medications can be prescribed

More and more Canadians with early cancer diagnoses or pronounced family histories of breast or ovarian cancers are considering BRCA1 and BRCA2 (BRCA1/2) genetic testing.

These 3500+ diagnostic and predictive single gene and genetic panel tests provide concrete, actionable insights that lead to informed decision making and personalized treatment.

>200 panel options, spanning more than 15 medical specialties, to provide actionable insight and informed decision making

To determine a cause for a complex genetic disorder, CentoXome® analyzes thousands of genes simultaneously, providing an alternative to single-gene tests or multigene panels to investigate the molecular basis of genetic disorders.

WGS is one of the latest genetic technologies that sequences the entire coding and non-coding regions of the genome to help provide answers for individuals with complex disease where other tests have not.